Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenaline Dosing in Cocktail Therapy for Total Knee Replacement Hemodynamics
ChiCTR2200063768Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of epinephrine in knee osteoarthritis (OA) (3 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: systolic pressure. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200063768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063768.